Sarah Snoda
Acute Care · Tucson, AZNPI 1538543863
Payments from drug & device makers
Across 32 payments — averaging $68.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$773
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$687
- Boston Scientific$133
- Teva Pharmaceuticals USA, Inc.$116
- Otsuka America Pharmaceutical, Inc.$105
- Baxter Healthcare$100
- plus $279 from 4 others
What the payments were for
- Food & beverage$2,193100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 7 | $773 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $687 |
| Boston Scientific | 1 | $133 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 1 | $105 |
| Baxter Healthcare | 1 | $100 |
| Abbott | 1 | $90 |
| Edwards Lifesciences | 2 | $82 |
| Boehringer Ingelheim | 1 | $71 |
| Atricure, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$291
- WATCHMAN Access System$133
- Austedo XR$116
- LifeVest$107
- REXULTI$105
- Hillrom - Carnation Ambulatory Monitor$100
How this compares
$2,193 in reported general payments places this provider in the 75th percentile of 482 acute care providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $23,569 |
| Memantine Hcl | 68 | $2,452 |
| Quetiapine Fumarate | 107 | $2,156 |
| Levothyroxine Sodium | 132 | $2,149 |
| Potassium Chloride | 29 | $2,141 |
| Donepezil Hcl | 113 | $2,131 |
| Olanzapine | 19 | $1,462 |
| Lisinopril | 100 | $1,426 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 27 | $1,394 |
| Atorvastatin Calcium | 80 | $1,392 |
| Pantoprazole Sodium | 64 | $1,269 |
| Amlodipine Besylate | 94 | $1,259 |
| Rosuvastatin Calcium | 48 | $1,237 |
| Mirtazapine | 41 | $1,175 |
| Ropinirole Hcl | 15 | $1,169 |
Paid to pharmacies, not to this prescriber.
Other acute care in Tucson
- Nicole CiffoneTucson$162K
- Francisco MartinezTucson$10K
- Sabrina GreeneTucson$10K
- Resel VillanuevaTucson$8K
- Sydni BurkeTucson$8K
- April WeaverTucson$6K
- Susan BurnsTucson$6K
- Kristy KeatingTucson$6K
- Brenda MitchellTucson$5K
- Barbara MayerTucson$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.